ZA985709B - Encapsulated solution dosage forms of sertraline. - Google Patents

Encapsulated solution dosage forms of sertraline.

Info

Publication number: ZA985709B
Authority: ZA; South Africa
Prior art keywords: sertraline; dosage forms; solution dosage; encapsulated solution; encapsulated
Prior art date: 1997-07-01

Application number

ZA9805709A

Other languages

English (en)

Inventor

William John Curatolo

Ravi Mysore Shanker

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-30

Publication date

2000-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA985709(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-30 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-01-10 Publication of ZA985709B publication Critical patent/ZA985709B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

ZA9805709A 1997-07-01 1998-06-30 Encapsulated solution dosage forms of sertraline. ZA985709B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5140197P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
ZA985709B true ZA985709B (en)	2000-01-10

Family

ID=21971076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9805709A ZA985709B (en)	1997-07-01	1998-06-30	Encapsulated solution dosage forms of sertraline.

Country Status (40)

Country	Link
EP (1)	EP0980241B1 (fr)
JP (1)	JP3585245B2 (fr)
KR (1)	KR100371730B1 (fr)
CN (1)	CN1261792A (fr)
AP (1)	AP945A (fr)
AR (1)	AR015916A1 (fr)
AT (1)	ATE256457T1 (fr)
AU (1)	AU724635B2 (fr)
BG (1)	BG103917A (fr)
BR (1)	BR9809712A (fr)
CA (1)	CA2290973C (fr)
CO (1)	CO4940405A1 (fr)
DE (1)	DE69820608T2 (fr)
DK (1)	DK0980241T3 (fr)
DZ (1)	DZ2544A1 (fr)
EA (1)	EA001905B1 (fr)
ES (1)	ES2210760T3 (fr)
GT (1)	GT199800090A (fr)
HR (1)	HRP980378B1 (fr)
HU (1)	HUP0002250A3 (fr)
ID (1)	ID24673A (fr)
IL (1)	IL133075A0 (fr)
IS (1)	IS5266A (fr)
MA (1)	MA24586A1 (fr)
MY (1)	MY119728A (fr)
NO (1)	NO996492L (fr)
NZ (1)	NZ501252A (fr)
OA (1)	OA11246A (fr)
PA (1)	PA8454001A1 (fr)
PE (1)	PE97299A1 (fr)
PL (1)	PL337807A1 (fr)
PT (1)	PT980241E (fr)
SK (1)	SK282914B6 (fr)
TN (1)	TNSN98123A1 (fr)
TR (1)	TR199903282T2 (fr)
TW (1)	TW382597B (fr)
UA (1)	UA68350C2 (fr)
UY (1)	UY25070A1 (fr)
WO (1)	WO1999001113A1 (fr)
ZA (1)	ZA985709B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6727283B2 (en)	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
AP2001002119A0 (en) *	1998-10-13	2001-03-22	Pfizer Prod Inc	Sertraline oral concentrate.
CN1222283C (zh)	1999-09-03	2005-10-12	Apbi控股有限责任公司	利用快速起效的选择性5－羟色胺再摄取抑制剂来治疗性功能障碍的方法
WO2002017918A2 (fr)	2000-08-30	2002-03-07	Pfizer Products Inc.	Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
EP1375659A1 (fr) *	2002-06-18	2004-01-02	Laboratorio di Diagnostica Moleculare	Mélanges concentrés dans des capsules solubles pour la préparation facilitée de solutions chimiques ou biologiques
KR20050083875A (ko) *	2002-10-31	2005-08-26	알자 코포레이션	소수성 약물의 생체이용성을 증진시키는 약제학적 제형
WO2016020936A2 (fr) *	2014-07-21	2016-02-11	Patel Jayendrakumar Dasharathlal	Nouvelle forme posologique pharmaceutique orale de rétention gastrique
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69525847T2 (de) *	1994-09-19	2002-09-05	Dupont Pharmaceuticals Co., Wilmington	Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
ES2192217T3 (es) *	1995-07-17	2003-10-01	Pfizer	Sertralina para el tratamiento de pacientes tras un infarto de miocardio.

1998
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/fr not_active Application Discontinuation
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active Expired - Fee Related
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 CA CA002290973A patent/CA2290973C/fr not_active Expired - Fee Related
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-16 EP EP98923021A patent/EP0980241B1/fr not_active Expired - Lifetime
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/fr active
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
1999
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU724635B2 (en)	2000-09-28
PE97299A1 (es)	1999-10-13
JP2000512316A (ja)	2000-09-19
WO1999001113A1 (fr)	1999-01-14
BG103917A (bg)	2000-07-31
IS5266A (is)	1999-11-23
PL337807A1 (en)	2000-09-11
MA24586A1 (fr)	1998-12-31
BR9809712A (pt)	2000-07-11
HRP980378B1 (en)	2001-12-31
AP9801279A0 (en)	1998-06-30
TNSN98123A1 (fr)	2005-03-15
AP945A (en)	2001-02-28
OA11246A (en)	2002-11-19
EP0980241B1 (fr)	2003-12-17
IL133075A0 (en)	2001-03-19
SK282914B6 (sk)	2003-01-09
ID24673A (id)	2000-07-27
UA68350C2 (en)	2004-08-16
UY25070A1 (es)	2000-12-29
PT980241E (pt)	2004-03-31
CA2290973C (fr)	2003-06-17
KR100371730B1 (ko)	2003-02-07
HUP0002250A3 (en)	2001-01-29
DK0980241T3 (da)	2004-04-05
DZ2544A1 (fr)	2003-02-08
DE69820608T2 (de)	2004-12-23
HRP980378A2 (en)	1999-04-30
CO4940405A1 (es)	2000-07-24
CN1261792A (zh)	2000-08-02
CA2290973A1 (fr)	1999-01-14
NZ501252A (en)	2004-11-26
AR015916A1 (es)	2001-05-30
GT199800090A (es)	1999-12-21
TW382597B (en)	2000-02-21
PA8454001A1 (es)	2000-05-24
SK180599A3 (en)	2001-01-18
JP3585245B2 (ja)	2004-11-04
ES2210760T3 (es)	2004-07-01
MY119728A (en)	2005-07-29
EP0980241A1 (fr)	2000-02-23
HUP0002250A2 (hu)	2000-12-28
NO996492D0 (no)	1999-12-27
EA001905B1 (ru)	2001-10-22
KR20010013588A (fr)	2001-02-26
AU7545098A (en)	1999-01-25
TR199903282T2 (xx)	2000-08-21
ATE256457T1 (de)	2004-01-15
NO996492L (no)	2000-02-29
DE69820608D1 (de)	2004-01-29
EA199900963A1 (ru)	2000-08-28

Publication	Publication Date	Title
PH30784A (en)	1997-10-17	Encapsulated dosage forms.
ZA99454B (en)	2000-10-23	Novel dosage form.
ZA989251B (en)	2000-04-10	Potentiation of pharmaceuticals.
ZA982253B (en)	1999-09-17	Therapeutic compositions.
ZA987551B (en)	1999-02-23	Solid pharmaceutical dosage forms
ZA981029B (en)	1999-08-10	Pharmaceutical agents.
ZA9811504B (en)	2000-06-15	Novel pharmaceutical.
ZA9811506B (en)	2000-11-06	Novel pharmaceutical.
ZA985710B (en)	2000-01-10	Delayed-release dosage forms of sertraline.
ZA985709B (en)	2000-01-10	Encapsulated solution dosage forms of sertraline.
PL338781A1 (en)	2000-11-20	Dosage form
SI0980241T1 (en)	2004-04-30	Gelatine encapsulated solution dosage forms of sertraline
ZA982558B (en)	1999-09-27	Novel Pharmaceutical.
ZA985707B (en)	2000-01-10	Sertraline salts and sustained-release dosage forms of sertraline.
GB9718683D0 (en)	1997-11-05	Novel dosage form
GB9719261D0 (en)	1997-11-12	Dosage forms
GB9704978D0 (en)	1997-04-30	Dosage forms
EG23239A (en)	2004-09-29	Preparation of haemagel.
CA82556S (en)	1997-12-05	Capsule
GB2329335B (en)	2000-06-21	Medicament
IL120398A0 (en)	1997-07-13	Low dosage contraceptive
HUP9903097A3 (en)	2000-02-28	Medicament containing progestogen-anti-progestogen
GB9717408D0 (en)	1997-10-22	Active trioxanes
GB9726234D0 (en)	1998-02-11	Medicament
GB0002424D0 (en)	2000-03-22	Medicament